A Pro-Inflammatory Role of C5L2 in C5a-Primed Neutrophils for ANCA-Induced Activation

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Hao, Jian ^a,b   Wang, Chen ^a   Yuan, Jun ^a   Chen, Min ^a   Zhao, Ming Hui ^a  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

^b INNER MONGOLIA MEDICAL COLLEGE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; COMPLEMENT COMPONENT C5A; COMPLEMENT COMPONENT C5A RECEPTOR; COMPLEMENT COMPONENT C5L2 ANTIBODY; IMMUNOGLOBULIN G; LACTOFERRIN; MEMBRANE BOUND PROTEINASE 3; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY; PROTEINASE; UNCLASSIFIED DRUG;

ARTICLE; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; NEUTROPHIL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RESPIRATORY BURST;

ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ANTIBODIES, BLOCKING; ANTIBODIES, MONOCLONAL; CELL DEGRANULATION; CELL MEMBRANE; COMPLEMENT C5A; CULTURE MEDIA, CONDITIONED; HUMANS; NEUTROPHIL ACTIVATION; NEUTROPHILS; PEPTIDE HYDROLASES; PEROXIDASE; PROTEIN TRANSPORT; RECEPTOR, ANAPHYLATOXIN C5A; RECEPTORS, CHEMOKINE; RESPIRATORY BURST;

EID: 84878984885     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0066305     Document Type: Article

References (40)

1. Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, et al. (2013) 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 65: 1-11.
2. Falk RJ, Terrell RS, Charles LA, Jennette JC, (1990) Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci U S A 87: 4115-4119.
3. Charles LA, Caldas ML, Falk RJ, Terrell RS, Jennette JC, (1991) Antibodies against granule proteins activate neutrophils in vitro. J Leukoc Biol 50: 539-546.
4. Keogan MT, Esnault VL, Green AJ, Lockwood CM, Brown DL, (1992) Activation of normal neutrophils by anti-neutrophil cytoplasm antibodies. Clin Exp Immunol 90: 228-234.
5. Mulder AH, Heeringa P, Brouwer E, Limburg PC, Kallenberg CG, (1994) Activation of granulocytes by anti-neutrophil cytoplasmic antibodies (ANCA): a Fc gamma RII-dependent process. Clin Exp Immunol 98: 270-278.
6. Hewins P, Morgan MD, Holden N, Neil D, Williams JM, et al. (2006) IL-18 is upregulated in the kidney and primes neutrophil responsiveness in ANCA-associated vasculitis. Kidney Int 69: 605-615.
7. Xiao H, Schreiber A, Heeringa P, Falk RJ, Jennette JC, (2007) Alternative complement pathway in the pathogenesis of disease mediated by anti-neutrophil cytoplasmic autoantibodies. Am J Pathol 170: 52-64.
8. Huugen D, van Esch A, Xiao H, Peutz-Kootstra CJ, Buurman WA, et al. (2007) Inhibition of complement factor C5 protects against anti-myeloperoxidase antibody-mediated glomerulonephritis in mice. Kidney Int 71: 646-654.
9. Xing GQ, Chen M, Liu G, Heeringa P, Zhang JJ, et al. (2009) Complement activation is involved in renal damage in human antineutrophil cytoplasmic autoantibody associated pauci-immune vasculitis. J Clin Immunol 29: 282-291.
10. Chen M, Xing GQ, Yu F, Liu G, Zhao MH, (2009) Complement deposition in renal histopathology of patients with ANCA-associated pauci-immune glomerulonephritis. Nephrol Dial Transplant 24: 1247-1252.
11. Hao J, Meng LQ, Xu PC, Chen M, Zhao MH, (2012) p38MAPK, ERK and PI3K signaling pathways are involved in C5a-primed neutrophils for ANCA-mediated activation. PLoS One 7: e38317.
12. Gou SJ, Yuan J, Chen M, Yu F, Zhao MH, (2013) Circulating complement activation in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis. Kidney Int 83: 129-137.
13. Yuan J, Gou SJ, Huang J, Hao J, Chen M, et al. (2012) C5a and its receptors in human anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis. Arthritis Res Ther 14: R140.
14. Schreiber A, Xiao H, Jennette JC, Schneider W, Luft FC, et al. (2009) C5a receptor mediates neutrophil activation and ANCA-induced glomerulonephritis. J Am Soc Nephrol 20: 289-298.
15. Gerard NP, Hodges MK, Drazen JM, Weller PF, Gerard C, (1989) Characterization of a receptor for C5a anaphylatoxin on human eosinophils. J Biol Chem 264: 1760-1766.
16. Gerard NP, Gerard C, (1991) The chemotactic receptor for human C5a anaphylatoxin. Nature 349: 614-617.
17. Manthey HD, Woodruff TM, Taylor SM, Monk PN, (2009) Complement component 5a (C5a). Int J Biochem Cell Biol 41: 2114-2117.
18. Ward PA, (2009) Functions of C5a receptors. J Mol Med (Berl) 87: 375-378.
19. Kalant D, MacLaren R, Cui W, Samanta R, Monk PN, et al. (2005) C5L2 is a functional receptor for acylation-stimulating protein. J Biol Chem 280: 23936-23944.
20. Lee H, Whitfeld PL, Mackay CR, (2008) Receptors for complement C5a. The importance of C5aR and the enigmatic role of C5L2. Immunol Cell Biol 86: 153-160.
21. Gao H, Neff TA, Guo RF, Speyer CL, Sarma JV, et al. (2005) Evidence for a functional role of the second C5a receptor C5L2. FASEB J 19: 1003-1005.
22. Chen NJ, Mirtsos C, Suh D, Lu YC, Lin WJ, et al. (2007) C5L2 is critical for the biological activities of the anaphylatoxins C5a and C3a. Nature 446: 203-207.
23. Rittirsch D, Flierl MA, Nadeau BA, Day DE, Huber-Lang M, et al. (2008) Functional roles for C5a receptors in sepsis. Nat Med 14: 551-557.
24. Choi M, Rolle S, Rane M, Haller H, Luft FC, et al. (2003) Extracellular signal-regulated kinase inhibition by statins inhibits neutrophil activation by ANCA. Kidney Int 63: 96-106.
25. Schreiber A, Rolle S, Peripelittchenko L, Rademann J, Schneider W, et al. (2010) Phosphoinositol 3-kinase-gamma mediates antineutrophil cytoplasmic autoantibody-induced glomerulonephritis. Kidney Int 77: 118-128.
26. Raby AC, Holst B, Davies J, Colmont C, Laumonnier Y, et al. (2011) TLR activation enhances C5a-induced pro-inflammatory responses by negatively modulating the second C5a receptor, C5L2. Eur J Immunol 41: 2741-2752.
27. Bamberg CE, Mackay CR, Lee H, Zahra D, Jackson J, et al. (2010) The C5a receptor (C5aR) C5L2 is a modulator of C5aR-mediated signal transduction. J Biol Chem 285: 7633-7644.
28. Witko-Sarsat V, Cramer EM, Hieblot C, Guichard J, Nusbaum P, et al. (1999) Presence of proteinase 3 in secretory vesicles: evidence of a novel, highly mobilizable intracellular pool distinct from azurophil granules. Blood 94: 2487-2496.
29. Baker EN, Baker HM, (2005) Molecular structure, binding properties and dynamics of lactoferrin. Cell Mol Life Sci 62: 2531-2539.
30. Talor MV, Stone JH, Stebbing J, Barin J, Rose NR, et al. (2007) Antibodies to selected minor target antigens in patients with anti-neutrophil cytoplasmic antibodies (ANCA). Clin Exp Immunol 150: 42-48.
31. Guo RF, Ward PA, (2005) Role of C5a in inflammatory responses. Annu Rev Immunol 23: 821-852.
32. Porges AJ, Redecha PB, Kimberly WT, Csernok E, Gross WL, et al. (1994) Anti-neutrophil cytoplasmic antibodies engage and activate human neutrophils via Fc gamma RIIa. J Immunol 153: 1271-1280.
33. Reumaux D, Vossebeld PJ, Roos D, Verhoeven AJ, (1995) Effect of tumor necrosis factor-induced integrin activation on Fc gamma receptor II-mediated signal transduction: relevance for activation of neutrophils by anti-proteinase 3 or anti-myeloperoxidase antibodies. Blood 86: 3189-3195.
34. Hess C, Sadallah S, Schifferli JA, (2000) Induction of neutrophil responsiveness to myeloperoxidase antibodies by their exposure to supernatant of degranulated autologous neutrophils. Blood 96: 2822-2827.
35. Kettritz R, Schreiber A, Luft FC, Haller H, (2001) Role of mitogen-activated protein kinases in activation of human neutrophils by antineutrophil cytoplasmic antibodies. J Am Soc Nephrol 12: 37-46.
36. Cain SA, Monk PN, (2002) The orphan receptor C5L2 has high affinity binding sites for complement fragments C5a and C5a des-Arg(74). J Biol Chem 277: 7165-7169.
37. Okinaga S, Slattery D, Humbles A, Zsengeller Z, Morteau O, et al. (2003) C5L2, a nonsignaling C5A binding protein. Biochemistry 42: 9406-9415.
38. Scola AM, Johswich KO, Morgan BP, Klos A, Monk PN, (2009) The human complement fragment receptor, C5L2, is a recycling decoy receptor. Mol Immunol 46: 1149-1162.
39. Gavrilyuk V, Kalinin S, Hilbush BS, Middlecamp A, McGuire S, et al. (2005) Identification of complement 5a-like receptor (C5L2) from astrocytes: characterization of anti-inflammatory properties. J Neurochem 92: 1140-1149.
40. Zhang X, Schmudde I, Laumonnier Y, Pandey MK, Clark JR, et al. (2010) A critical role for C5L2 in the pathogenesis of experimental allergic asthma. J Immunol 185: 6741-6752.